Indianapolis, IN, United States of America

Min You

This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min You. Retrieved from https://idiyas.com/inventor/min-you

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min You - Innovator in Modulating P-glycoproteins

Introduction

Min You is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate the activity of P-glycoproteins. Her innovative work addresses critical challenges in drug resistance, enhancing the efficacy of therapeutic drugs.

Latest Patents

Min You holds 1 patent that focuses on compounds and methods for modulating P-glycoprotein activity. This patent discloses methods utilizing compounds derived from various sources to overcome multidrug resistance. The therapeutic applications of her inventions include enhancing the performance of chemotherapeutic drugs and antibiotics, which can significantly impact patient treatment outcomes.

Career Highlights

Min You is affiliated with the University of Illinois, where she continues her research and development efforts. Her work is pivotal in advancing the understanding of drug interactions and improving therapeutic strategies for patients facing drug resistance.

Collaborations

Min You has collaborated with notable colleagues, including John M Pezzuto and Baoliang Cui. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Min You's contributions to the field of pharmacology through her innovative patent work exemplify her commitment to addressing drug resistance. Her research holds promise for improving therapeutic efficacy and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…